GSA CAPITAL PARTNERS LLP - NYMOX PHARMACEUTICAL CORP ownership

NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 46 filers reported holding NYMOX PHARMACEUTICAL CORP in Q2 2017. The put-call ratio across all filers is 4.51 and the average weighting 0.0%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of NYMOX PHARMACEUTICAL CORP
ValueSharesWeighting
Q3 2020$47,000
-44.0%
18,912
-18.2%
0.01%
+60.0%
Q1 2017$84,000
-9.7%
23,107
-34.0%
0.01%
-16.7%
Q4 2016$93,000
-7.9%
35,007
+13.3%
0.01%
+20.0%
Q3 2016$101,000
+14.8%
30,907
+17.5%
0.01%0.0%
Q2 2016$88,000
-62.1%
26,307
-72.3%
0.01%
-66.7%
Q1 2016$232,00094,8940.02%
Other shareholders
NYMOX PHARMACEUTICAL CORP shareholders Q2 2017
NameSharesValueWeighting ↓
Corrigan Financial, Inc. 302,252$102,7660.03%
Virtu Financial LLC 13,324$50.00%
Bleakley Financial Group, LLC 80,000$27,2000.00%
Beaird Harris Wealth Management, LLC 24,400$8,2960.00%
One Day In July LLC 10,000$3,4000.00%
Cubic Asset Management, LLC 10,000$3,4000.00%
WMS Partners, LLC 18,000$6,1200.00%
Simplicity Solutions, LLC 80,000$27,2000.00%
WELLS FARGO & COMPANY/MN 3,296$1,1210.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of NYMOX PHARMACEUTICAL CORP shareholders